Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$17.11
-$0.39 (-2.2%)
Closing Price on November 8, 2024
TEVA Articles
Reuters: China will send an envoy to the US to discuss the yuan. Reuters: European carriers who lost money on the Apple (AAPL) iPhone won’t do the same in their deals to sell the iPad....
Published:
These are some of the top movers in the world of BioHealth investing. It is usual that drug companies and biotech stocks have major volatility around news and these are examples of that today. ...
Published:
Twitter has, by most estimates, 75 million visitors a month, which makes it one of the largest social networds in the world. All major media companies have a presence on Twitter and some are followed...
Published:
These are this Tuesday’s top 10 analyst upgrades, downgrades, and initiations seen in Wall Street research calls during the pre-market hours. It is more skewed to downgrades, something we have...
Published:
Last Updated:
Reuters: Toyota (TM) said it found no electronic safety problems with its cars. Reuters: China said it was committed to US debt but worried about gold. Reuters: Japanese car companies are...
Published:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
These are ten of the top analyst upgrades and downgrades that are independent of earnings news from Wall Street this Thursday morning: ABB (ABB) Cut to Hold at Societe Generale. Air Products (APD)...
Published:
These are the top pre-market analyst upgrades and positive research calls from Wall Street we have seen this Wednesday morning with more than two hours until the market opens: Allergan (AGN) Started...
Published:
Last Updated:
According to Reuters, a poll of economists says the Japanese economy is likely to get worse. Reuters reports that Trump Entertainment may file for Chapter 11. Reuters writes that California may have...
Published:
Last Updated:
It is getting rather thin in analyst coverage, but these are the top ten analyst upgrades and downgrades we have seen this Wednesday morning: ActivIdentity (NASDAQ: ACTI) Started as Buy at Stanford...
Published:
Last Updated:
Below are some of the top analyst calls we are seeing from Wall Street firms this Thursday morning: Biogen Idec (BIIB) Raised to Buy at Lazard. Cowen (COWN) Raised to Outperform at KBW. Mylan Labs...
Published:
These are some of the early bird analyst upgrades and positive calls we are seeing this Thursday morning with more than two hours to the open: Auxilium Pharma (AUXL) Started as Outperform at...
Published:
These are only some of the early bird analyst calls that we have seen in early Monday pre-market trading, but these are some of the more active stock names: American International Group (NYSE: AIG)...
Published:
According to Reuters, global companies may start to issue profit warnings as business slows overseas. Reuters reports that InBev is sticking to it offer to buy Anheuser-Bush (BUD). Reuters reports...
Published:
These are ten of the analyst calls we have seen in the early hours of trading this Monday morning: Alcatel-Lucent (NYSE: ALU) Raised to Neutral from Underperform at Merrill Lynch. Atheros...
Published: